Alembic Pharmaceuticals Limited (APLLTD.BO)
INR 850.0
(0.7%)
INR 850.0
(0.7%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 16.43 Billion INR | 11.41% |
| 2022 | 14.75 Billion INR | -8.35% |
| 2021 | 16.09 Billion INR | 8.31% |
| 2020 | 14.86 Billion INR | 25.15% |
| 2019 | 11.87 Billion INR | 22.77% |
| 2018 | 9.67 Billion INR | 31.79% |
| 2017 | 7.33 Billion INR | 15.99% |
| 2016 | 6.32 Billion INR | 11.05% |
| 2015 | 5.69 Billion INR | 48.97% |
| 2014 | 3.82 Billion INR | 23.07% |
| 2013 | 3.1 Billion INR | 16.47% |
| 2012 | 2.66 Billion INR | 3.13% |
| 2011 | 2.58 Billion INR | 18.02% |
| 2010 | 2.19 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 16.43 Billion INR | 11.41% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 16.43 Billion INR | 0.0% |
| 2023 Q2 | 15.39 Billion INR | 0.0% |
| 2022 Q4 | 14.75 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 14.75 Billion INR | -8.35% |
| 2022 Q2 | 15.88 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 16.09 Billion INR | 8.31% |
| 2021 Q4 | 16.09 Billion INR | 0.0% |
| 2021 Q2 | 14.99 Billion INR | 0.0% |
| 2020 Q4 | 14.86 Billion INR | 0.0% |
| 2020 FY | 14.86 Billion INR | 25.15% |
| 2020 Q2 | 12.8 Billion INR | 0.0% |
| 2019 Q2 | 12.29 Billion INR | 0.0% |
| 2019 Q4 | 11.87 Billion INR | 0.0% |
| 2019 FY | 11.87 Billion INR | 22.77% |
| 2018 FY | 9.67 Billion INR | 31.79% |
| 2018 Q4 | 9.67 Billion INR | 0.0% |
| 2018 Q2 | 8.47 Billion INR | 0.0% |
| 2017 Q4 | 7.33 Billion INR | 0.0% |
| 2017 Q2 | 6.39 Billion INR | 0.0% |
| 2017 FY | 7.33 Billion INR | 15.99% |
| 2016 Q4 | 6.32 Billion INR | 0.0% |
| 2016 FY | 6.32 Billion INR | 11.05% |
| 2016 Q2 | 6.28 Billion INR | 0.0% |
| 2015 FY | 5.69 Billion INR | 48.97% |
| 2015 Q2 | 4.75 Billion INR | 0.0% |
| 2015 Q4 | 5.69 Billion INR | 0.0% |
| 2014 Q4 | 3.82 Billion INR | 0.0% |
| 2014 FY | 3.82 Billion INR | 23.07% |
| 2014 Q2 | 3.84 Billion INR | 0.0% |
| 2013 Q4 | 3.1 Billion INR | 0.0% |
| 2013 FY | 3.1 Billion INR | 16.47% |
| 2013 Q2 | 2.84 Billion INR | 0.0% |
| 2012 Q2 | 5 Billion INR | 0.0% |
| 2012 FY | 2.66 Billion INR | 3.13% |
| 2012 Q4 | 2.66 Billion INR | 0.0% |
| 2011 FY | 2.58 Billion INR | 18.02% |
| 2010 FY | 2.19 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aurobindo Pharma Limited | 98.08 Billion INR | 83.243% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -146.559% |
| Granules India Limited | 13 Billion INR | -26.373% |
| Indoco Remedies Limited | 3.53 Billion INR | -365.513% |
| Achyut Healthcare Limited | 568 Thousand INR | -2893456.338% |
| Ajanta Pharma Limited | 8.28 Billion INR | -98.409% |
| Alkem Laboratories Limited | 26.61 Billion INR | 38.24% |
| Alpa Laboratories Limited | 136.65 Million INR | -11927.105% |
| Brooks Laboratories Limited | 96.1 Million INR | -17000.97% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -621.224% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -1041.045% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -1287.571% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 74.139% |
| Eris Lifesciences Limited | 1.89 Billion INR | -769.451% |
| FDC Limited | 3.88 Billion INR | -322.625% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 34.6% |
| Gufic Biosciences Limited | 2 Billion INR | -719.794% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -15616.075% |
| Ipca Laboratories Limited | 24.71 Billion INR | 33.495% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -10859.125% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -16676.979% |
| Lasa Supergenerics Limited | 190.43 Million INR | -8530.497% |
| Laurus Labs Limited | 18.45 Billion INR | 10.939% |
| Lupin Limited | 49.53 Billion INR | 66.823% |
| Mankind Pharma Limited | 15.53 Billion INR | -5.799% |
| Medicamen Biotech Limited | 593.75 Million INR | -2668.058% |
| Medico Remedies Limited | 163.37 Million INR | -9960.108% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | -134.624% |
| Piramal Pharma Limited | 21.75 Billion INR | 24.466% |
| RPG Life Sciences Limited | 1.01 Billion INR | -1527.267% |
| Sigachi Industries Limited | 707.2 Million INR | -2223.987% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 83.345% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -610.887% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -7696.125% |
| Unichem Laboratories Limited | 7.04 Billion INR | -133.233% |
| Wanbury Limited | 360.23 Million INR | -4462.449% |
| Windlas Biotech Limited | 621.89 Million INR | -2542.815% |
| ZIM Laboratories Limited | 812.62 Million INR | -1922.497% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 52.249% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 48.381% |
| Hester Biosciences Limited | 755.81 Million INR | -2074.541% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -1406.315% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -5586.065% |
| Bal Pharma Limited | 878.11 Million INR | -1771.67% |
| Strides Pharma Science Limited | 11.26 Billion INR | -45.932% |
| Venus Remedies Limited | 1.21 Billion INR | -1250.596% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -155.661% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -131.761% |
| Shilpa Medicare Limited | 3.44 Billion INR | -376.488% |
| Aarti Drugs Limited | 4.85 Billion INR | -238.254% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -286.861% |
| Suven Life Sciences Limited | 7.08 Million INR | -231874.594% |
| Ind-Swift Limited | 640.91 Million INR | -2464.365% |
| Valiant Laboratories Limited | 100.15 Million INR | -16310.128% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -227.066% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -356.92% |
| Themis Medicare Limited | 705.74 Million INR | -2228.808% |
| Hikal Limited | 3.03 Billion INR | -441.137% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 27.883% |
| Sequent Scientific Limited | 3.46 Billion INR | -374.693% |
| Novartis India Limited | 448.6 Million INR | -3563.709% |
| Wockhardt Limited | 6.4 Billion INR | -156.803% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -27.446% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -64360.133% |
| Neuland Laboratories Limited | 3.5 Billion INR | -369.017% |
| Morepen Laboratories Limited | 2.48 Billion INR | -561.134% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -41112.136% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -1229.297% |